NASDAQ · Medical - Distribution

Henry Schein, Inc. (HSIC) Stock

$84.01 -0.73% NASDAQ: HSIC Healthcare

Valuation

MetricValue
Price$84.01
Market Cap$9.57B
P/E Ratio24.53
P/B Ratio3.05
P/S Ratio0.71
EPS (TTM)$3.27
52-Week High$92.18
52-Week Low$61.95
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE12.37%
ROA3.54%
ROCE9.81%
Gross Margin5.75%
Operating Margin5.75%
Net Margin2.96%
Debt/Equity1.21
Current Ratio1.38

Annual Financials (USD)

Metric20212022202320242025
Revenue$12.4B$12.6B$12.3B$12.7B$13.2B
Operating Profit$855.0M$938.0M$714.0M$729.0M$758.0M
Net Profit$624.0M$538.0M$416.0M$390.0M$398.0M
EPS$4.45$3.91$3.16$3.05$3.27
Op Margin6.9%7.4%5.8%5.8%5.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$8.5B$8.6B$10.6B$10.2B$11.2B
Total Liabilities$3.8B$3.9B$5.4B$5.4B$6.4B
Cash$118.0M$117.0M$171.0M$122.0M$156.0M
Borrowings$1.2B$1.5B$2.7B$2.9B$3.7B

Latest News

Henry Schein (HSIC) Could Be 3% Undervalued As Earnings Come Into Focus Simply Wall St. · Jul 22, 2026 HSIC: Lowering target price to $90.00 Argus Research · Jul 22, 2026 Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 a.m. ET Business Wire · Jul 21, 2026 Will Henry Schein (HSIC) Beat Estimates Again in Its Next Earnings Report? Zacks · Jul 20, 2026 Leerink Partners Adjusts Price Target on Henry Schein to $88 From $83, Maintains Market Perform Rating MT Newswires · Jul 20, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$710.0M$602.0M$500.0M$848.0M$712.0M
Investing Cash Flow$-756.0M$-372.0M$-1.3B$-617.0M$-616.0M
Financing Cash Flow$-490.0M$-542.0M$-199.0M$-699.0M$-914.0M
Net Cash Flow$-303.0M$-1.0M$54.0M$-49.0M$34.0M
Free Cash Flow$631.0M$506.0M$313.0M$661.0M$573.0M

Valuation & Return Ratios

MetricValue
PEG Ratio2.41
EV / EBITDA12.92
FCF Yield5.57%
Quick Ratio0.73
Interest Coverage4.87
Return 1Y30.11%
Return 3Y13.22%
Return 5Y6.44%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACHAccendra Health, Inc. $0.43 -3.43% -0.12 $32.78M 0.00%
CAHCardinal Health, Inc. $237.57 -0.58% 31.93 $55.64B 0.89%
CORCencora, Inc. $323.85 +0.78% 22.21 $63.01B 0.80%
MCKMcKesson Corporation $938.84 +0.92% 24.26 $109.92B 0.41%
NVSTEnvista Holdings Corporation $23.00 +1.23% 39.76 $3.74B 0.00%

About Henry Schein, Inc.

Henry Schein, Inc. is led by CEO Frederick Lowery, employs 25,000 people, headquartered in Melville, US, publicly traded since 1995.

Henry Schein, Inc. (HSIC) stock trades at $84.01 with a market capitalization of $9.57B. The stock is valued at a price-to-earnings (P/E) ratio of 24.53, price-to-book of 3.05, price-to-sales of 0.71. Over the past 52 weeks the stock has ranged between $61.95 and $92.18, and currently trades 8.9% below its 52-week high.

On profitability, Henry Schein, Inc. generates a return on equity (ROE) of 12.37%, above the typical market average, return on capital employed of 9.81%, an operating margin of 5.75%, a net profit margin of 2.96%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides